Manuel Mendez to serve as Executive Vice President, Commercial Operations for bioMérieux Inc.
Asia
Europe, Middle East, Africa
North America
bioMérieux and GlaxoSmithKline Enter into Alliance to Develop Molecular Theranostic Test for Cancer Treatment Selection
10 May, 2010
bioMérieux and GlaxoSmithKline (GSK) have signed an agreement to develop a novel molecular test for cancer. In this new collaboration, the two companies will develop a theranostic test to aid oncologists in choosing the appropriate treatment for metastatic melanoma (skin cancer).
bioMérieux - First Quarter 2010 Business Review
21 April, 2010
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2010.
bioMérieux and Knome Sign Strategic Partnership
21 April, 2010
Exclusive agreement to bring state-of-the-art genome sequencing technology to the in vitro diagnostics market. bioMérieux takes equity stake in Knome.
bioMérieux's 2010 Odyssey Hits the Road in the Battle Against Superbugs
20 April, 2010
High-tech Mobile Laboratory Brings Education and Training to Healthcare and Quality Assurance Professionals Across North America
bioMérieux Acquires From Anagnostec - Database and Expertise for Rapid Microbial Identification using Mass Spectrometry
12 April, 2010
bioMérieux announces today that it has agreed on the terms for the acquisition of certain assets from AnagnosTec, a company based in the greater Berlin area, specialized in microbial identification with MALDI-TOF* mass spectrometry technology.
bioMérieux's PREVI™ Isola Wins the 2010 - Medical Design Excellence Award
08 April, 2010
The award highlights the automated media streaker’s breakthrough technology.
bioMérieux Launches Industry-First Vancomycin-Resistant Enterococci (VRE) Screening Tool
11 March, 2010
Cost-effective chromogenic media ideal for VRE identification in hospitals and laboratories
bioMérieux Results 2009
08 March, 2010
The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met on Friday, March 5, 2010 to approve the consolidated financial statements for the year ended December 31, 2009. The meeting was chaired by Alain Mérieux and attended by the Statutory Auditors. The financial statements have been audited and the Statutory Auditors are in the process of issuing an unqualified opinion.
bioMérieux 2015
08 March, 2010
A powerful strategic vision for 2010-2015, driven by innovation and international development.